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Introduction: Systemic rheumatic conditions are often accompanied by intraocular inflammatory disease (termed
uveitis). Despite the frequent manifestation of uveitis with arthritis, very little is understood of the underlying
mechanisms that mediate the eye’s susceptibility to disease. The genetically susceptible SKG mouse strain develops
arthritis that arises from an inherent mutation that disrupts T-cell antigen receptor signal transduction and thymic
selection. The ensuing T-cell–mediated disease is further modulated through exposure to microbial triggers.
The purpose of this study was to elucidate how a genetically determined shift in the T-cell repertoire toward
self-reactive T cells that drive arthritis influences uveitis in SKG mice.
Methods: SKG mice (BALB/c mice that harbor the W163C point mutation in zeta-chain-associated protein kinase
70 [i.e., ZAP-70]) were housed under arthritis-resistant, specific pathogen–free conditions. Arthritis was induced by
intraperitoneal injection with fungal glucans (zymosan or curdlan). Arthritis onset and severity were evaluated by
clinical scoring, histopathology and infrared imaging within the joints. Periocular traits involving blepharoconjunctivitis
were evaluated by clinical scoring and histology. Eyes were evaluated for signs of anterior uveitis using intravital
videomicroscopy to document cell-trafficking responses within the iris vasculature and stroma and by histology to
detect inflammatory infiltrate and tissue damage within the anterior and posterior eye segments.
Results: Exposure to zymosan resulted in the predicted arthritic, sexually dimorphic phenotype in SKG mice. The eyes
of SKG mice exhibited episodic intravascular cellular responses to zymosan or curdlan as indicated by significant
increases in leukocyte–endothelium interactions akin to ocular vasculitis. However, despite the significant increase in
early cell-trafficking responses, cellular infiltration into the iris stroma was not observed and histopathological signs
indicative of a sustained uveitis were absent. Instead, eyes of SKG mice developed blepharoconjunctivitis that
coincided with arthritis and exhibited sexual dimorphism.
Conclusions: This study underscores the complexity surrounding the pathogenesis of uveitis and its relationship with
arthritis. The findings suggest that distinct mechanisms exist by which pathogenic autoimmune T cells target the eyes
versus joints, which likely involves the environmental context but nonetheless should be taken into account in the
identification and development of effective therapies for each organ.* Correspondence: rosenzwh@ohsu.edu
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A number of systemic rheumatic conditions, such as an-
kylosing spondylitis, psoriatic arthropathy, Behçet dis-
ease, juvenile idiopathic arthritis, sarcoidosis, reactive
arthritis/Reiter syndrome and Blau syndrome, are com-
monly associated with intraocular inflammatory disease,
or uveitis. Uveitis itself encompasses a heterogeneous
group of immune-mediated disorders that may also
occur in isolation and whose etiology may be infectious
or non-infectious (i.e., autoimmune) [1, 2]. The under-
lying mechanisms of uveitis are poorly understood;
however, it is interesting to speculate whether ongoing
systemic rheumatic disease and increased frequency of
autoreactive T cells that target specific systemic organs
and tissues share commonalities with T cells that traffic
to the eyes, which would render them susceptible to
subsequent ocular disease.
One prevailing theory is that chronic inflammatory
diseases such as arthritis and uveitis arise from complex
interactions between genetic predisposition and environ-
mental triggers. The role of adaptive immunity, par-
ticularly of T cells, in uveitis has traditionally been the
subject of intense investigation [3–7]. This is in large
part due to the strong genetic association with human
leukocyte antigen (HLA) [8–10], which is thought to be
involved in aberrant antigen presentation by the major
histocompatibility complex and subsequent development
of autoreactive T-cell responses. The presence of auto-
reactive T cells has been a consistently reported feature
of uveitis in patients, and pharmacologic modulation
of T-cell effector functions can have beneficial effects
[11, 12]. Given that T cells are considered important
cellular mediators of many arthritic diseases, one may
reason that their aberrant autoreactive responses also
contribute to coincident uveitis.
To address whether thymic production of pathogenic
autoimmune T cells could be a primary cause of ocular
disease, we undertook studies in the genetically predis-
posed arthritic SKG mice. SKG mice, first described by
Sakaguchi and colleagues [13], develop self-reactive T
cells as a consequence of a point mutation in the Src
homology 2 domain of zeta-chain-associated protein
kinase 70 (ZAP-70), a critical mediator of T-cell receptor
signaling responses. This mutation impairs T-cell sig-
naling capacity and consequently disrupts positive and
negative selection in the thymus [14], resulting in the
survival of self-reactive T cells that would otherwise have
been deleted. A chronic and progressive polyarthritis de-
velops, which also coincides with features of systemic in-
flammation such as increased autoantibody titers and
increased levels of cytokines, including interleukin (IL)-1,
IL-6 and tumor necrosis factor α [13, 15, 16]. The arthritis
aspect of disease is transferable by CD4+ T cells, and
the type 17 helper T-cell (Th17) effector response isconsidered a driving pathogenic response [17]. Extraarti-
cular manifestations, including interstitial pneumonitis,
vasculitides, subcutaneous necrobiotic nodules and colitis
[13, 15, 16, 18], have also been described. A recent report
by Ruutu et al. [19] was particularly interesting and
exciting to us in that SKG mice that had received systemic
injections with fungal cell wall components such as
β-glucan developed anterior uveitis. Thus, generation of
an autoreactive T-cell population could affect other target
organs, such as the eye.
An interesting caveat to disease development in SKG
mice is the prerequisite of an environmental trigger. It
has been observed that SKG mice do not develop arth-
ritis in microbially clean housing environments [13, 20].
This indicates that the genetic predisposition causing
persistent autoreactive T cells is not sufficient, but that a
second signal is required for disease. Indeed, the disease
phenotype can be reproduced when SKG mice are ex-
posed to microbial stimuli such as the fungal cell wall
components zymosan or β-glucan curdlan [20, 21].
Thus, even though this is a T-cell–mediated disease, en-
vironmental factors are a qualification. This is an im-
portant distinction from other experimental models of
autoimmunity, wherein a break in tolerance is caused by
immunization with self-proteins. For example, in experi-
mental autoimmune uveitis, rodents immunized with
retinal self-antigens develop autoimmunity targeted to
the posterior eye [22–24]. Thus, disease modeled in
SKG mice aptly suits the purpose of this study because
it is a T-cell–intrinsic disease arising from a break in
central tolerance involving environmental cues.
In this study, we tested the hypothesis that generation
of an autoreactive T-cell population that drives arthritis
in SKG mice is an underlying factor in the development
of uveitis. We observed the predicted onset and progres-
sion of arthritis in SKG mice exposed to zymosan or
curdlan, which occurred more rapidly in females than in
males. The generation of the autoreactive T-cell reper-
toire that gives rise to arthritis, however, did not trans-
late to sustained uveitis, despite the ongoing dynamic
cellular responses within the iris vasculature. Interest-
ingly, arthritis instead coincided with blepharoconjunc-
tivitis that followed a similar sexual dimorphism. The
observations in this study highlight the complexity sur-
rounding immunological mechanisms by which T cells
are involved in uveitis and the manner in which auto-
reactive T cells target the eye.
Methods
Mice
SKG mice on the BALB/c background were maintained
under specific pathogen–free (SPF) conditions at the VA
Portland Health Care System, Portland, OR, USA. All
studies were carried out in accordance with the National
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Laboratory Animals and with approval granted by the VA
Portland Health Care System Institutional Animal Care
and Use Committee. Genotype was confirmed as previ-
ously described [13]. Briefly, DNA was isolated from tail
tissue, and the region of the Zap-70 gene containing nu-
cleotide 489 (site of G-to-T substitution in SKG mice) was
amplified by PCR. Restriction enzyme digestion with
BstNI was performed on the PCR product, which cleaved
only wild-type (WT) DNA. The resulting products were
visualized by agarose electrophoresis. All experiments
were carried out in accordance with institutional guide-
lines for animal welfare.
Induction and clinical grading of arthritis
SKG mice (7–8 weeks of age) were administered either a
single intraperitoneal (i.p.) injection of 3 mg of zymosan,
a cell wall component prepared from Saccharomyces
cerevisiae, or a β-1,3-glucan, curdlan, prepared from
Alcaligenes faecalis (InvivoGen, San Diego, CA, USA).
After injection, the mice were evaluated as a function of
time for the onset and severity of arthritis using a previ-
ously described grading system adapted for this model
[20, 25]. Arthritis was scored on a weekly basis by a
masked observer using the following defined criteria:
0 = no joint swelling or redness, 1 = any sign of arthritis
(i.e., swelling or redness in any single digit of the wrist or
ankle), 2 = mild swelling or redness in wrist and/or ankle
coinciding with two or more swollen digits, 3 = severe
redness and/or swelling in all digits and throughout the
wrist or ankle with reduced ability to grip, and 4 = de-
formities of fingers and severe ankylosis extending from
wrist and/or ankle up to larger joints. Mice were scored
for all paws, and scores were summed per mouse such
that the clinical grade for a single mouse could range from
0 to a maximum of 16. For calculation of disease inci-
dence, a mouse was considered positive for arthritis when
a total clinical score was ≥1 maintained for ≥2 weeks.
Scoring of periocular manifestations
Periocular changes surrounding the eyeball (e.g., eyelid
inflammation [blepharitis] or conjunctival discharge [indi-
cating conjunctivitis]) were features observed coinciden-
tally upon disease induction. Owing to the lack of an
established system for scoring severity of these individual
characteristics, a binary scoring system was applied to in-
dicate the presence of blepharitis (score of 1); the presence
of blepharitis coinciding with conjunctivitis, more severe
eyelid swelling and/or ocular discharge (score of 2); or the
absence of any inflammation (i.e., normal-appearing eye
as in naive BALB/c controls) (score of 0). Mice were
scored individually for each eye, and scores were summed
per mouse such that the clinical grade for a single mouse
could range from 0 to a maximum of 4.Histological evaluation
At the indicated times, the eyes and ankles of each ani-
mal were collected, fixed in 10 % neutral-buffered for-
malin and prepared for tissue sectioning as previously
reported [26, 27]. Histological assessment of the ankle
joints was performed on decalcified ankles. The eyes
were embedded in paraffin, sectioned (7 μm) through
the pupillary–optic nerve axis and stained with he-
matoxylin and eosin. At least three sections obtained at
four different depths within each eye were scored in a
masked fashion, and the number of infiltrated leukocytes
present in the aqueous humor of the anterior segment and
vitreous body of the posterior segment was quantified.
Infrared in vivo imaging
Upon termination of the experiment, imaging was per-
formed on legs and spines dissected from animals that
had been given ProSense (NEV10003; PerkinElmer,
Waltham, MA, USA) injections for detection of areas of
signal localization and activation within the joints as
previously described [26, 28]. Hair and skin were re-
moved from the legs and spines for optimal signal detec-
tion, then scanned with 685-nm and 785-nm lasers and
white light-emitting diodes using the Pearl Imager
(model 5700; LI-COR Biosciences, Lincoln, NE, USA).
Images of matched pairs of light sources were acquired
by using a charge-coupled device detector and Pearl
Cam software (LI-COR Biosciences), which normalized
acquisitions so that the same intensity value was dis-
played with the same color and grayscale value on all
images. Regions of interest (ROIs) were analyzed using
Image Studio software (LI-COR Biosciences) and the
small animal image analysis application. The mean dif-
ferences in infrared signaling in the ROIs were normal-
ized to those of corresponding ROIs from healthy, naive
WT-BALB/c mice.
Intravital videomicroscopy
The in vivo cellular trafficking response within the iris vas-
culature and tissue was evaluated every 2 weeks using in-
travital videomicroscopy as previously described [26, 27].
At the time of imaging, mice were anesthetized with iso-
flurane and leukocytes were visualized with rhodamine 6G
(35 mg/kg; Sigma-Aldrich, St. Louis, MO, USA), a dye
taken up by all leukocytes when administered via i.p. injec-
tion. Digital videos (10 seconds each) were acquired in
three independent regions of the iris using a monochrome
camera (Kappa optronics, Gleichen, Germany). Measure-
ments (diameter and length) of vessels and stromal tissue
area, as well as quantification of rolling, adherent and
infiltrating leukocytes, were performed offline by masked
observers using ImageJ software (National Institutes of
Health, Bethesda, MD, USA). Both eyes of each mouse
were evaluated.
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The results are presented as the mean ± SEM. Statistical
analysis of differences between experimental groups was
performed by using analysis of variance or two-tailed
Student’s t tests. For nonparametric data (i.e., clinical
arthritis scores or binary periocular scores), the Mann–
Whitney U test was used (Prism; GraphPad Software, La
Jolla, CA, USA). Statistical significance was set at p < 0.05.
Results
Exposure to zymosan results in chronic and progressive
polyarthritis in genetically predisposed SKG mice
Consistent with prior reports [20], SKG mice housed
under the SPF conditions at our facility remained healthy
and did not spontaneously develop overt signs of arthritis
(data not shown). However, the reported arthritis pheno-
type was reproduced with an acute exposure to microbial
stimuli such as the β-glucan–containing and fungus-
associated product zymosan [20, 21]. As shown in Fig. 1,
systemic exposure to zymosan at 7–8 weeks of age re-
sulted in the development of a progressive polyarthritis inFig. 1 Zymosan exposure results in chronic and progressive polyarthritis in
injection of zymosan at 7–8 weeks of age. Animals were subsequently eval
injection (i.e., 23–24 weeks of age). a Representative photographs depict he
animal (clinical grade 0, left) and an inflamed, arthritic ankle (clinical grade
photographs are stained histopathological sections obtained at 16 weeks a
severity and faster onset in zymosan-challenged females compared with m
development (data not graphed). d Visualization of deposition and activatio
zymosan injection. Knees and ankle and tarsometatarsal joints of legs obtai
that had received zymosan injection (Diseased). e Whole-body NIR images
zymosan injection in a diseased (after zymosan injection) SKG mouse (right
of interest of SKG mice using NIR imaging technology, wherein all values w
*p < 0.05 indicates effect of zymosan versus naive SKG mice; Ψp < 0.05 sex
n = 12–18 mice/group (combined two individual experiments). A significan
zymosan injections compared with the non-treated group for onset and seSKG mice within the ankles and wrists, which translated
histologically into thickening of synovial lining and infil-
tration of sublining coincident with bone and cartilage de-
struction and pannus formation (Fig. 1a). The female SKG
mice developed earlier onset and more severe arthritis
compared with males (Fig. 1b, c), further confirming the
sex × gene interaction in the disease phenotype of SKG
mice [16, 29]. Ultimately, both sexes achieved a near
100 % incidence of arthritis (i.e., 16 weeks postinjection)
(Fig. 1c). Using infrared imaging technology, which we
have found closely predicts the extent of joint pathology
[27, 30], we were able to more sensitively quantify inflam-
matory arthritis within the joints, thereby showing signifi-
cant inflammation within the knee that extended down
the tibiotarsus to the ankle and tarsometatarsal joints
(Fig. 1d). Some inflammation was detected within the
lower spine as well, wherein positive signals localized to
the vertebral column just below the sacrum and within
the upper caudal vertebrae of the tail (Fig. 1e). Quan-
tification of changes in localized infrared signals compared
with naive BALB/c mice (Fig. 1f) showed minimal toSKG mice. SKG mice were administered a single intraperitoneal
uated clinically for arthritis every week to 16 weeks after zymosan
althy, uninflamed ankle and digit within the ankle of a naive SKG
4, right) of an SKG mouse that received a zymosan injection. Below the
fter zymosan injection. Clinical arthritis evaluation revealed increased
ales (b, c). Naive SKG mice of either sex did not show any arthritis
n of labeled near-infrared (NIR) probe within the legs at 16 weeks after
ned from a naive BALB/c mouse (Healthy) and an arthritic SKG mouse
illustrate changes to the base of the spine occurring at 16 weeks after
) versus a healthy, naive BALB/c mouse (left). f Quantification of regions
ere normalized to background signaling from naive BALB/c mice.
comparison between SKG mice that received a zymosan injection;
t response was observed for both male and female mice that received
verity of arthritis (b, c)
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ing was significantly enhanced upon zymosan exposure in
both sexes. It was noted, however, that the ankle and/or
tarsometatarsal joints demonstrated the most robust in-
flammatory response to zymosan versus the knee or spine,
thereby indicating a predilection for smaller synovial
joints, such as condyloid and saddle joints, in their suscep-
tibility to this type of disease.
Development of blepharoconjunctivitis coincides with
arthritis in SKG mice
We observed an obvious periocular response to zymosan
that manifested initially as eyelid inflammation (i.e.,
swelling and redness similar to blepharitis). With zymo-
san, this feature was markedly enhanced and progressed
to involve massive cellular infiltration in and around the
meibomian glands (Fig. 2a, b). Such pathological changes
coincided with mucous discharge on the ocular surface,
as is typical in conjunctivitis. Evaluating the onset of this
blepharoconjunctivitis as it relates to arthritis progres-
sion using basic, binomial criteria, we found that the
milder form of blepharitis, which localized to the pos-
terior eyelid, occurred spontaneously in approximatelyFig. 2 Evaluation of blepharoconjunctivitis development in SKG mice. a Ph
BALB/c mouse. b Photograph and stained histological section of an SKG mou
(blepharitis) and conjunctival discharge. Arrowheads indicate thickened lid
infiltration visualized by histopathology (arrows). The presence of such periocu
zymosan injection) using a binary scoring system to assay for the complete a
of 1) or blepharitis with coinciding conjunctivitis and/or discharge (as shown
percentage incidence (score ≥1; panel d) were plotted as a function of time s
for both male and female mice that received a zymosan injection versus SKG
effect of sex among SKG mice that received a zymosan injection; n = 12–18 m
included as a negative control group (scores = 0)25 % of SKG mice compared with 0 % in healthy BALB/c
control mice (data not shown). With zymosan exposure,
the presence of blepharoconjunctivitis in at least one eye
preceded the clinical onset of arthritis and progressed
throughout the course of disease (Fig. 2c, d). Interestingly,
blepharoconjunctivitis also followed a similar sexual di-
morphism in that females demonstrated a more severe
condition (Fig. 2c). These data suggest an autoimmune,
T-cell–intrinsic component as an underlying mechanism
of blepharitis and/or conjunctivitis that could be akin to
prior reports of skin inflammation [13, 19].
Disease triggered by zymosan in SKG mice results in
dynamic cellular responses within the vasculature
of the eye
Given the overt periocular manifestations (Fig. 2) and a
prior report of the presence of an anterior uveitis in
SKG mice [19], we sought to further evaluate the onset
and kinetics of intraocular inflammation in arthritic
SKG mice. Using intravital videomicroscopy, we per-
formed a thorough examination of cell-trafficking re-
sponses within the iris, which is the tissue consistently
affected by anterior uveitis. Intravital videomicroscopy isotograph and stained histological section of a naive, healthy control
se that had received a zymosan injection, showing eyelid inflammation
margin, which coincides with epithelial hyperplasia and leukocytic
lar manifestations in SKG mice was graded over time (0–16 weeks after
bsence (score of 0 as shown in panel a), the presence of blepharitis (score
in panel b; score of 2). Total score per mouse (sum of both eyes) (c) and
ince zymosan injection. A prominent response (p < 0.05) was observed
mice that did not receive a zyomsan injection (c). Ψp < 0.05 indicates
ice/group (combined two individual experiments). BALB/c mice were
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quantification of cells within the vessels and tissues of
the iris but also ascertainment of dynamic behavioral
changes longitudinally over time in their rolling, adhe-
sion or infiltrative properties that can result in ocular
damage [26, 27, 30]. Such behaviors are exemplified in
the representative still images shown in Fig. 3a, b, which
are derived from videomicroscopy movies that show this
in more detail (Additional files 1 and 2). Naive SKG
mice did not spontaneously develop any intraocular in-
flammation, as shown by negligible cellular responses in-
volving leukocyte–endothelium interactions (Fig. 3a, c–e,)
akin to those in healthy, uninflamed eyes of BALB/c mice.
However, with zymosan injection, a marked increase in
leukocyte rolling and adhesion along the endothelium was
observed (Fig. 3b–d). Quantification from video data
showed the significant rolling and adhesion cellular re-
sponses that were increased with zymosan exposure
(Fig. 3c, d), which peaked around 10 weeks and again at
16 weeks (Fig. 3c, d). This cellular response involving
leukocyte–endothelium interactions is likely indicative of
an ocular vasculitis that ensues upon endothelial cell acti-
vation and upregulation of adhesion molecules (e.g., selec-
tins, integrins) that are known to mediate such cellular
interactions. Notably, this response was detectable beforeFig. 3 Intravital videomicroscopy reveals cellular rolling and adhesion, but
show representative still images from videomicroscopy of the iris vasculatu
of naive SKG mice (a) and from inflamed eyes of SKG mice that had receiv
biweekly over a 16-week period in naive SKG mice or in SKG mice that had
numbers of rolling, adherent and infiltrated cells per square millimeter of vess
and naive SKG mice within each sex; Ψ indicates sex effect within SKG mice t
two individual experiments)clinical arthritis onset, and, unlike the progressive nature
of arthritis, these ocular cellular changes were episodic in
that they followed a phasic response.
Interestingly, such early intravascular cell-trafficking
responses did not appear to lead to increased cellular in-
filtration into the iris stroma (Fig. 3e). We further eva-
luated ocular inflammation by histology at both 10
weeks and 16 weeks after zymosan injection, which had
appeared by intravital videomicroscopy to be “peak” time
points for intravascular responses. As shown in Fig. 4,
histopathological examination did not reveal any signifi-
cant features of sustained ocular disease. The number of
leukocytes quantified within the aqueous humor of the
anterior segment and the vitreous body of the posterior
segment was negligible (Fig. 4a) and statistically indistin-
guishable from the number in naive SKG controls or
naive BALB/c mice (data not shown). Figure 4 shows
representative images of anterior (Fig. 4b) and posterior
(Fig. 4c) eye segments from an arthritic animal at 10
weeks following zymosan exposure. Consistent with the
intravital data (Fig. 3) indicative of vasculitis, some
engorgement of iris vessels was noted. However, other
signs present during clinical uveitis, such as fibrin de-
position within the chambers, keratic precipitates and
optic nerve inflammation, were not observed in diseasednot infiltration, within the microvasculature of the eye. Photographs
re and rhodamine-labeled hematopoietic cells from uninflamed eyes
ed a zymosan injection (b). The iris vasculature and tissue were imaged
received a zymosan injection, and videos were analyzed offline for
el or iris tissue (c–e). *p < 0.05 indicates comparison between zymosan
hat had received a zymosan injection; n = 12–18 mice/group (combined
Fig. 4 Histopathological evaluation reveals absence of uveitis in animals that had received a zymosan injection. Eyes of SKG mice were evaluated
at 10 weeks or 16 weeks after zymosan injection for signs of ocular disease. The number of leukocytes within the aqueous humor of the anterior
segment and within the vitreous body of the posterior segment in response to zymosan was quantified (a). Representative photographs show
the anterior (b) and posterior (c) eye segments at 10 weeks after zymosan injection. A anterior, P posterior, AC anterior chamber, C cornea, Ir iris,
Lb limbus, CB ciliary body, L lens, V vitreous, R retina. Statistical significance was not achieved for zymosan versus naive SKG mice of either sex at
either time point. n = 17–23 mice/group or versus BALB/c controls (combined three individual experiments)
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leukocyte–endothelium interactions occurring within
the iris microvasculature of SKG mice, uveitis as defined
pathologically did not develop.
Curdlan-triggered disease in SKG mice results in arthritis
and intra-vasculature inflammatory responses within
the eye
In addition to zymosan, purified β-glucans such as cur-
dlan have been described as potent triggers of arthritis
in SKG mice and as having periocular disease manifesta-
tions [20]. Thus, to further evaluate the discordant dis-
ease responses we observed in the joints and eyes of
SKG mice injected with zymosan, we reevaluated uveitis
and arthritis elicited in response to curdlan. Similarly to
zymosan-injected animals, systemic curdlan injection
reproduced the arthritic, sexually dimorphic phenotype
in SKG mice (Fig. 5a, b). We found that a prior exposure
to curdlan resulted in development of progressive poly-
arthritis in SKG mice (Fig. 5a, b), albeit to a slightly
lesser degree compared with zymosan (Fig. 1). The fe-
male mice developed an earlier onset and a more severe
form of arthritis than did males, but 100 % incidence oc-
curred by 10 weeks in both sexes (Fig. 5b). We found
that prior exposure to curdlan elicited a periocular re-
sponse akin to that with zymosan, albeit to a lesser de-
gree of severity in its clinical manifestations (Fig. 5c–e).
Analysis of intravital microscopy videos of curdlan-
injected SKG mice revealed dramatic intravascular leu-
kocyte dynamics indicative of a vasculitis response at 10
weeks that involved leukocyte rolling and adhesion along
the endothelium (Fig. 5f ). However, such cellular inter-
actions did not lead to iris stromal tissue infiltration
(Fig. 5f ). This observation was confirmed by histologicalevaluation, which showed an absence of cells within ocu-
lar tissue or the chambers (Fig. 5g). These findings indi-
cate that zymosan and the purified β-glucan curdlan are
both potent triggers of coincident periocular inflamma-
tion and arthritis but do not induce uveitis.
Discussion
On the basis of a prior report [19], we sought to further
elucidate how generation of a self-reactive T-cell popula-
tion that causes arthritis confers susceptibility to uveitis.
We confirmed the sex × gene interaction in arthritis de-
velopment in the SKG mouse strain in response to both
zymosan and curdlan. Moreover, we expanded upon the
description of the coincident periocular disease that oc-
curred in arthritic SKG mice, which indicates the in-
volvement of self-reactive T cells in the eyelid and/or
conjunctival inflammation. This may be a relevant obser-
vation because psoriasis-like skin inflammation is a sign
common to many rheumatic diseases in which arthritis
also develops. Blepharitis (i.e., eyelid inflammation) can
lead to dry eye syndrome, which in some forms is be-
lieved to have an autoimmune component. Despite such
periocular manifestations in our mice, however, our data
do not support the hypothesis that a common autoreac-
tive T-cell population causes both arthritis and uveitis.
We observed dynamic cellular responses within the
vasculature of the eye that were indicative of episodic
vasculitis, but these ongoing cellular responses did not
lead to infiltration into the iris tissue or any other histo-
pathological sign of uveitis.
Our findings reveal a significant increase in leukocyte–
endothelium interactions within the iris vasculature that
is likely indicative of vasculitis. This response peaked
around 10 weeks after zymosan injection, then decreased
Fig. 5 Curdlan exposure reproduces arthritic phenotype in SKG mice but does not result in uveitis. Animals evaluated clinically for arthritis for 10
weeks following curdlan injection exhibited increasingly severe arthritic disease (a) and increased incidence (b) over time, with females showing
worse disease and earlier onset than males. c–e The onset and severity of periocular manifestations in SKG mice were graded in response to
curdlan using the binary scoring system (as in Fig. 2) and images of the presence of blepharitis (score of 1; e, left) or blepharitis with coinciding
conjunctivitis and/or discharge (score of 2; e, right). f Analysis of intravital videomicroscopy of iris vasculature and tissue at 10 weeks following
curdlan injection revealed significant increases in intravascular leukocyte rolling and adhesion in curdlan-injected animals compared with naive SKG
mice. These increases were not accompanied by leukocyte infiltration into extravascular iris tissue. g Quantification of eye histological sections from
naive versus curdlan-injected animals at 10 weeks show no difference in the number of cells infiltrating into the anterior and posterior chambers in
curdlan-injected mice. *p < 0.05 for comparison between curdlan-injected and non-injected SKG mice (observed in both sexes); Ψp < 0.05 indicates
comparison between sexes in curdlan-injected SKG mice; n = 12 mice/group (combined two individual experiments)
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reminiscent of episodic flares that are known to occur
clinically in patients with anterior uveitis. Such flares
could be indicative of changes in vascular permeability
that we were unable to detect at the cellular level and/or
of endothelial activation resulting from spikes in serum
levels of cytokines, although the progression and/or
kinetics of cytokine responses in the circulation needed
to determine this have not been fully characterized. Such
acute immune responses could also be caused by en-
vironmental and/or microbial triggers elicited by micro-
biota that are known to influence systemic immune
responses. Ultimately, endothelial dysfunction caused
directly or indirectly as a bystander effect of systemicautoimmunity is very relevant clinically, as increased
morbidity is associated with systemic diseases such as
rheumatoid arthritis. In other words, generalized inflam-
mation that damages blood vessels can potentiate or ag-
gravate diseases such as atherosclerosis and stroke.
Using two different methodological approaches (intravital
videomicroscopy and histopathology), we were unable to
detect any signs of intraocular inflammation that could be
classified as clinical uveitis. This suggests that the blood–
ocular barrier remained intact even in the face of ongoing
systemic inflammation and vascular dysfunction. This
finding indicates that autoreactive mechanisms driving
T-cell–mediated disease targeted to the joint, skin or
vasculature may differ from those of the eye and/or that
Lee et al. Arthritis Research & Therapy  (2015) 17:218 Page 9 of 10additional signals are required for complete expression in
the eye for uveitis to develop. Thus, we cannot conclude
that a T-cell–intrinsic defect that causes arthritis also leads
to uveitis. This may be analogous to the case of HLA-B27.
HLA-B27 is strongly associated genetically with spon-
dylarthritis, particularly with ankylosing spondylitis and
associated acute anterior uveitis (AAU). For example, pos-
session of HLA-B27 antigen increases the relative risk of
AAU by 26 times [10, 31, 32]. Animal models of HLA-
B27–associated disease have clearly demonstrated the
direct connection between HLA-B27 expression and mul-
tisystem inflammatory disease involving spondylarthritis
[33, 34]; yet, uveitis is not an observed spontaneous
phenotype in the HLA-B27 transgenic animal models
[35, 36]. Therefore, what is sufficient for arthritis induc-
tion is not necessarily sufficient for uveitis development.
The dissonant responses among the eyes and joints are ex-
emplified also in a murine model of spondylarthritis in-
duced by active immunization with proteoglycan [25, 27].
Arthritis is mediated by a Th1-dependent mechanism; yet,
deficiency in interferon γ worsened the uveitis aspect of
disease [27], thereby indicating that a discordant mechan-
ism involving Th1 effector responses can exist between
the eyes and joints (i.e., despite being target organs in the
same disease). Thus, the same mechanisms do not neces-
sarily have similar effects in the eyes and joints.
In a recent study of SKG mice, Ruutu and colleagues
reported anterior uveitis in approximately 25 % of dis-
eased SKG mice upon β-glucan exposure [19]. In our
present study, in which we examined ocular disease
within the same time frame as their study, we were un-
able to recapitulate this particular phenotype of disease
induced in SKG mice. However, we were able to con-
sistently reproduce other reported features of disease
induced in SKG mice by fungal components, such as the
periocular manifestations and lung-associated pneumon-
itis (data not shown), which is known to occur in ap-
proximately 100 % of the animals and is believed to be
caused by the same T-cell clone as in arthritis [18]. Intri-
guingly, in the prior report [19], Ruutu and colleagues
did not observe the lung-associated disease, suggesting
that different disease penetrance within the SKG mice
may occur between the two animal facilities. Another
phenotypic difference noted between the two studies is
the extent of axial disease. Consistent with the prior re-
port [19], our studies reveal ongoing inflammation
within the lower vertebral column, just below the sac-
rum and within the upper caudal vertebrae of the tail;
however, such localized spinal inflammation did not lead
to the same extensive inflammatory arthritis compared
with that in the smaller synovial joints, such as the ankle
and/or tarsometatarsal joints. Such differences in pheno-
type are intriguing and could relate to different micro-
bial triggers that influence certain aspects of disease. Itis conceivably noteworthy that the episodic peaks in
ocular vasculitis detected in our experiments coincided
with the time frames Ruutu et al. reported for the onset
of uveitis. This suggests additional cellular mechanisms
not intrinsic to T cells that could participate in underlying
mechanisms of uveitis. Another potential consideration is
the environmental triggers and/or colony differences re-
lated to microbiota colonization in each holding facility.
Indeed, in a recent report, researchers observed a similar
discordance between arthritis and ileitis incidence under
germ-free conditions [37], supporting a link between
organ-specific tissue pathology and the microbiota. Col-
lectively, these observations underscore the complexity
surrounding extraarticular manifestations such as uveitis
in the context of arthritic disease.Conclusions
The complexity surrounding uveitis, regardless of whe-
ther it is associated with a systemic rheumatic disease,
has presented considerable challenges to understanding
its pathogenesis. These studies using SKG mice provide
proof-of-concept that a break in central tolerance in
which autoreactive T cells are generated and can cause
chronic and progressive arthritis is not necessarily suffi-
cient for the development of uveitis. T cells clearly play a
role in autoimmunity, but the manner in which they are
regulated and target the eye are complicated and unlikely
to mirror the T-cell responses that occur in the joints.
These distinct differences have implications for the identi-
fication of safe and effective new therapies that are opti-
mal for the control of immune responses in each organ.Additional files
Additional file 1: Movie file showing a lack of any active cellular
response within the microvasculature of the eye from a naive SKG
mouse. (MOV 15651 kb)
Additional file 2: Movie file showing the ongoing cellular response
within the microvasculature of the eye from a zymosan-challenged
SKG mouse. (MOV 12376 kb)
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